Short Interest in Sandoz Group AG (OTCMKTS:SDZNY) Rises By 25.4%

Sandoz Group AG (OTCMKTS:SDZNY) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 68,600 shares, a growth of 25.4% from the February 28th total of 54,700 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 94,300 shares, the short-interest ratio is currently 0.7 days.

Analyst Upgrades and Downgrades

Separately, UBS Group lowered Sandoz Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, February 3rd.

Sandoz Group Price Performance

SDZNY opened at $41.00 on Thursday. The stock’s 50-day moving average price is $45.16 and its 200 day moving average price is $43.86. Sandoz Group has a 12-month low of $27.79 and a 12-month high of $49.81.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.